Heide Ford
Concepts (420)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Homeodomain Proteins | 31 | 2026 | 525 | 7.150 |
Why?
| | Protein Tyrosine Phosphatases | 23 | 2026 | 166 | 5.330 |
Why?
| | Epithelial-Mesenchymal Transition | 13 | 2025 | 218 | 3.380 |
Why?
| | Breast Neoplasms | 27 | 2025 | 2411 | 3.350 |
Why?
| | Gene Expression Regulation, Neoplastic | 29 | 2025 | 1429 | 3.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 17 | 2026 | 456 | 2.670 |
Why?
| | Nuclear Proteins | 17 | 2026 | 739 | 2.550 |
Why?
| | Triple Negative Breast Neoplasms | 6 | 2025 | 219 | 2.270 |
Why?
| | Cell Line, Tumor | 41 | 2026 | 3538 | 1.970 |
Why?
| | Transforming Growth Factor beta | 7 | 2012 | 466 | 1.910 |
Why?
| | Neoplasm Metastasis | 17 | 2025 | 693 | 1.890 |
Why?
| | Neoplastic Stem Cells | 10 | 2025 | 402 | 1.830 |
Why?
| | Neoplasms | 17 | 2025 | 2944 | 1.830 |
Why?
| | MicroRNAs | 6 | 2018 | 695 | 1.620 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 6 | 2017 | 54 | 1.470 |
Why?
| | Vascular Endothelial Growth Factor C | 3 | 2020 | 16 | 1.440 |
Why?
| | Drug Resistance, Neoplasm | 10 | 2026 | 889 | 1.290 |
Why?
| | Cell Transformation, Neoplastic | 6 | 2015 | 314 | 1.280 |
Why?
| | Signal Transduction | 20 | 2025 | 5234 | 1.170 |
Why?
| | DNA-Binding Proteins | 7 | 2025 | 1467 | 1.050 |
Why?
| | Muscle Development | 2 | 2022 | 114 | 1.050 |
Why?
| | Sarcoma, Ewing | 2 | 2023 | 103 | 1.040 |
Why?
| | Up-Regulation | 9 | 2018 | 840 | 0.990 |
Why?
| | Protein Phosphatase 2 | 3 | 2025 | 41 | 0.950 |
Why?
| | Cell Plasticity | 2 | 2025 | 37 | 0.890 |
Why?
| | Transcription Factors | 7 | 2022 | 1728 | 0.880 |
Why?
| | Zebrafish Proteins | 2 | 2022 | 314 | 0.870 |
Why?
| | Rhabdomyosarcoma | 2 | 2024 | 65 | 0.870 |
Why?
| | Mammary Glands, Human | 4 | 2010 | 71 | 0.860 |
Why?
| | Chemokine CCL2 | 1 | 2025 | 112 | 0.860 |
Why?
| | Animals | 52 | 2026 | 38030 | 0.840 |
Why?
| | Oncogene Proteins, Fusion | 4 | 2024 | 212 | 0.820 |
Why?
| | Disease Progression | 5 | 2025 | 2857 | 0.780 |
Why?
| | Proto-Oncogene Proteins c-myc | 3 | 2025 | 157 | 0.720 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 481 | 0.690 |
Why?
| | Cerebellar Neoplasms | 1 | 2023 | 169 | 0.680 |
Why?
| | Medulloblastoma | 1 | 2023 | 208 | 0.670 |
Why?
| | NF-kappa B | 1 | 2025 | 674 | 0.670 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 3 | 2017 | 31 | 0.660 |
Why?
| | Neuropilin-2 | 1 | 2020 | 4 | 0.660 |
Why?
| | Antineoplastic Agents | 9 | 2024 | 2218 | 0.650 |
Why?
| | Mammary Neoplasms, Experimental | 5 | 2012 | 61 | 0.650 |
Why?
| | Mice | 31 | 2026 | 18266 | 0.630 |
Why?
| | Cell Transdifferentiation | 2 | 2010 | 31 | 0.620 |
Why?
| | Humans | 79 | 2026 | 145625 | 0.610 |
Why?
| | Mice, SCID | 9 | 2019 | 360 | 0.600 |
Why?
| | Cadherins | 2 | 2014 | 201 | 0.590 |
Why?
| | Cell Differentiation | 10 | 2026 | 1979 | 0.590 |
Why?
| | Pluripotent Stem Cells | 1 | 2020 | 78 | 0.580 |
Why?
| | Breast | 1 | 2020 | 154 | 0.580 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 2 | 2016 | 66 | 0.570 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 2 | 2023 | 30 | 0.560 |
Why?
| | RNA-Binding Protein EWS | 2 | 2023 | 31 | 0.560 |
Why?
| | Transcriptional Activation | 3 | 2018 | 368 | 0.550 |
Why?
| | Neoplasm Proteins | 3 | 2018 | 443 | 0.550 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 1 | 2018 | 15 | 0.550 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 66 | 0.550 |
Why?
| | Epithelial Cells | 5 | 2012 | 1118 | 0.540 |
Why?
| | Receptor, Notch1 | 1 | 2018 | 62 | 0.530 |
Why?
| | Mice, Inbred NOD | 6 | 2019 | 598 | 0.520 |
Why?
| | Zinc Finger Protein GLI1 | 1 | 2017 | 23 | 0.510 |
Why?
| | Cell Proliferation | 12 | 2024 | 2497 | 0.510 |
Why?
| | Anion Transport Proteins | 1 | 2017 | 8 | 0.500 |
Why?
| | Paracrine Communication | 1 | 2017 | 67 | 0.490 |
Why?
| | Down-Regulation | 2 | 2015 | 612 | 0.480 |
Why?
| | Female | 37 | 2025 | 79080 | 0.470 |
Why?
| | Genetic Heterogeneity | 1 | 2016 | 66 | 0.470 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 245 | 0.460 |
Why?
| | Ribosomal Proteins | 1 | 2015 | 93 | 0.440 |
Why?
| | Twist-Related Protein 1 | 1 | 2015 | 8 | 0.440 |
Why?
| | Gene Regulatory Networks | 3 | 2026 | 319 | 0.440 |
Why?
| | Mammary Glands, Animal | 3 | 2010 | 124 | 0.430 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 594 | 0.430 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2019 | 1156 | 0.430 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2016 | 530 | 0.430 |
Why?
| | Cell Cycle | 4 | 2013 | 595 | 0.430 |
Why?
| | Mesoderm | 3 | 2009 | 147 | 0.420 |
Why?
| | Epithelium | 3 | 2009 | 295 | 0.420 |
Why?
| | Receptors, Transforming Growth Factor beta | 2 | 2012 | 54 | 0.410 |
Why?
| | Retina | 2 | 2026 | 330 | 0.410 |
Why?
| | Tumor Microenvironment | 3 | 2025 | 745 | 0.410 |
Why?
| | Neoplasm Transplantation | 6 | 2014 | 238 | 0.400 |
Why?
| | Protein Binding | 9 | 2025 | 2239 | 0.400 |
Why?
| | MCF-7 Cells | 4 | 2020 | 133 | 0.390 |
Why?
| | Branchio-Oto-Renal Syndrome | 2 | 2013 | 7 | 0.390 |
Why?
| | Interferons | 2 | 2025 | 186 | 0.390 |
Why?
| | Transcription, Genetic | 3 | 2014 | 1429 | 0.380 |
Why?
| | Molecular Targeted Therapy | 2 | 2015 | 446 | 0.370 |
Why?
| | Lung Neoplasms | 4 | 2019 | 2674 | 0.370 |
Why?
| | Superoxide Dismutase | 1 | 2014 | 307 | 0.370 |
Why?
| | Small Molecule Libraries | 3 | 2025 | 113 | 0.370 |
Why?
| | Gene Expression Regulation, Developmental | 5 | 2017 | 899 | 0.360 |
Why?
| | Lymphangiogenesis | 1 | 2012 | 27 | 0.360 |
Why?
| | Genes, Tumor Suppressor | 1 | 2012 | 84 | 0.350 |
Why?
| | Smad7 Protein | 1 | 2012 | 20 | 0.350 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 173 | 0.340 |
Why?
| | Mice, Nude | 7 | 2017 | 665 | 0.330 |
Why?
| | Genes, Homeobox | 3 | 2022 | 50 | 0.310 |
Why?
| | Apoptosis | 4 | 2019 | 2436 | 0.310 |
Why?
| | Bone Neoplasms | 1 | 2012 | 271 | 0.300 |
Why?
| | Mice, Inbred BALB C | 4 | 2019 | 1244 | 0.300 |
Why?
| | Cyclin A | 3 | 2009 | 17 | 0.290 |
Why?
| | Embryonic Development | 1 | 2010 | 124 | 0.290 |
Why?
| | Enzyme Inhibitors | 7 | 2024 | 820 | 0.290 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2025 | 928 | 0.280 |
Why?
| | Tyrosine | 4 | 2024 | 217 | 0.270 |
Why?
| | Prognosis | 6 | 2019 | 4331 | 0.270 |
Why?
| | Cell Movement | 5 | 2020 | 950 | 0.270 |
Why?
| | Genomic Instability | 1 | 2008 | 64 | 0.260 |
Why?
| | Cell Hypoxia | 2 | 2025 | 247 | 0.250 |
Why?
| | Ovarian Neoplasms | 3 | 2012 | 598 | 0.240 |
Why?
| | Synthetic Lethal Mutations | 1 | 2026 | 4 | 0.240 |
Why?
| | Heterografts | 3 | 2017 | 143 | 0.230 |
Why?
| | Eukaryotic Initiation Factor-3 | 1 | 2025 | 10 | 0.230 |
Why?
| | Gene Knockdown Techniques | 3 | 2016 | 334 | 0.220 |
Why?
| | Central Nervous System Neoplasms | 2 | 2026 | 177 | 0.220 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 1996 | 0.220 |
Why?
| | STAT1 Transcription Factor | 1 | 2025 | 68 | 0.220 |
Why?
| | Cell Survival | 3 | 2026 | 1102 | 0.220 |
Why?
| | Gene Amplification | 1 | 2005 | 116 | 0.210 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 1 | 2024 | 26 | 0.210 |
Why?
| | Neoplasm Invasiveness | 3 | 2024 | 503 | 0.210 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2024 | 76 | 0.210 |
Why?
| | Myosins | 1 | 2024 | 131 | 0.210 |
Why?
| | Rosaniline Dyes | 1 | 2024 | 15 | 0.200 |
Why?
| | Protein Biosynthesis | 2 | 2025 | 447 | 0.200 |
Why?
| | Kaplan-Meier Estimate | 2 | 2020 | 959 | 0.200 |
Why?
| | Zebrafish | 2 | 2022 | 533 | 0.200 |
Why?
| | Protein Stability | 2 | 2018 | 175 | 0.200 |
Why?
| | Peptides | 3 | 2025 | 991 | 0.200 |
Why?
| | Eye Proteins | 1 | 2024 | 93 | 0.200 |
Why?
| | Drug Design | 1 | 2024 | 179 | 0.190 |
Why?
| | Gene Expression Profiling | 4 | 2012 | 1790 | 0.190 |
Why?
| | Integrins | 1 | 2023 | 88 | 0.190 |
Why?
| | Mitochondrial Proteins | 1 | 2024 | 263 | 0.180 |
Why?
| | Models, Biological | 4 | 2017 | 1758 | 0.180 |
Why?
| | Proto-Oncogene Proteins | 1 | 2026 | 615 | 0.180 |
Why?
| | Immunohistochemistry | 3 | 2018 | 1709 | 0.180 |
Why?
| | Myogenin | 1 | 2022 | 15 | 0.180 |
Why?
| | Glioblastoma | 2 | 2026 | 349 | 0.180 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2022 | 16 | 0.180 |
Why?
| | MyoD Protein | 1 | 2022 | 31 | 0.180 |
Why?
| | HEK293 Cells | 3 | 2024 | 746 | 0.170 |
Why?
| | Cell Cycle Proteins | 1 | 2026 | 629 | 0.170 |
Why?
| | Transplantation, Heterologous | 4 | 2012 | 165 | 0.170 |
Why?
| | Tumor Cells, Cultured | 4 | 2019 | 878 | 0.170 |
Why?
| | Brain Neoplasms | 3 | 2024 | 1324 | 0.160 |
Why?
| | Trans-Activators | 3 | 2026 | 371 | 0.160 |
Why?
| | Cell Dedifferentiation | 2 | 2010 | 31 | 0.160 |
Why?
| | Chromatin | 1 | 2024 | 557 | 0.160 |
Why?
| | BRCA1 Protein | 1 | 2020 | 83 | 0.150 |
Why?
| | Hedgehog Proteins | 1 | 2020 | 194 | 0.150 |
Why?
| | Prostatic Neoplasms | 2 | 2024 | 972 | 0.150 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 12 | 0.140 |
Why?
| | Oxygen | 1 | 2024 | 996 | 0.140 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2026 | 700 | 0.140 |
Why?
| | Phosphorylation | 3 | 2024 | 1717 | 0.140 |
Why?
| | Cyclin A1 | 3 | 2009 | 5 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 973 | 0.140 |
Why?
| | Mutation | 1 | 2009 | 4082 | 0.130 |
Why?
| | Antigens, CD | 2 | 2014 | 559 | 0.130 |
Why?
| | Cell Growth Processes | 2 | 2008 | 47 | 0.130 |
Why?
| | Blotting, Western | 3 | 2011 | 1176 | 0.130 |
Why?
| | RNA, Small Interfering | 2 | 2017 | 630 | 0.130 |
Why?
| | Veratrum Alkaloids | 1 | 2017 | 20 | 0.130 |
Why?
| | Maxilla | 1 | 2017 | 36 | 0.130 |
Why?
| | DNA Damage | 3 | 2026 | 437 | 0.130 |
Why?
| | Basigin | 1 | 2017 | 24 | 0.120 |
Why?
| | RNA, Messenger | 3 | 2018 | 2783 | 0.120 |
Why?
| | Proteolysis | 2 | 2017 | 174 | 0.120 |
Why?
| | Carbolines | 1 | 1996 | 35 | 0.120 |
Why?
| | Promoter Regions, Genetic | 3 | 2010 | 1236 | 0.120 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 1996 | 27 | 0.120 |
Why?
| | Protein Structure, Tertiary | 2 | 2009 | 834 | 0.120 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 98 | 0.120 |
Why?
| | Clone Cells | 1 | 2016 | 259 | 0.120 |
Why?
| | Biphenyl Compounds | 1 | 1996 | 67 | 0.120 |
Why?
| | Multigene Family | 2 | 2008 | 209 | 0.120 |
Why?
| | Oxidoreductases | 1 | 1996 | 91 | 0.120 |
Why?
| | Endothelin-1 | 1 | 2017 | 177 | 0.110 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 153 | 0.110 |
Why?
| | Allosteric Regulation | 3 | 2024 | 100 | 0.110 |
Why?
| | Epigenesis, Genetic | 2 | 2024 | 705 | 0.110 |
Why?
| | Cytidine | 2 | 1993 | 9 | 0.110 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 405 | 0.110 |
Why?
| | Tumor Burden | 2 | 2017 | 326 | 0.110 |
Why?
| | Structure-Activity Relationship | 3 | 2024 | 561 | 0.110 |
Why?
| | Zinc Finger E-box Binding Homeobox 2 | 1 | 2014 | 6 | 0.110 |
Why?
| | Mass Spectrometry | 1 | 2018 | 728 | 0.110 |
Why?
| | Claudins | 1 | 2014 | 23 | 0.110 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2022 | 697 | 0.110 |
Why?
| | Cell Nucleus | 2 | 2009 | 584 | 0.110 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2015 | 126 | 0.110 |
Why?
| | Gene Expression | 3 | 2009 | 1461 | 0.100 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 92 | 0.100 |
Why?
| | Autophagy | 1 | 2016 | 290 | 0.100 |
Why?
| | Genes, MHC Class I | 2 | 2005 | 37 | 0.100 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2014 | 98 | 0.100 |
Why?
| | Gene Expression Regulation | 1 | 2023 | 2591 | 0.100 |
Why?
| | RNA Interference | 2 | 2017 | 470 | 0.100 |
Why?
| | Survival Rate | 1 | 2019 | 2078 | 0.100 |
Why?
| | Transfection | 3 | 2017 | 914 | 0.100 |
Why?
| | G1 Phase | 1 | 2013 | 64 | 0.100 |
Why?
| | Pyrimidines | 1 | 2017 | 530 | 0.100 |
Why?
| | Child | 2 | 2023 | 22638 | 0.100 |
Why?
| | Biomedical Research | 1 | 2020 | 724 | 0.100 |
Why?
| | Amino Acid Sequence | 6 | 2014 | 2088 | 0.100 |
Why?
| | Cyclin-Dependent Kinase 6 | 1 | 2013 | 49 | 0.100 |
Why?
| | Cluster Analysis | 2 | 2012 | 494 | 0.090 |
Why?
| | Pyridines | 1 | 2017 | 606 | 0.090 |
Why?
| | Disease-Free Survival | 1 | 2014 | 777 | 0.090 |
Why?
| | Antibodies, Neoplasm | 1 | 2012 | 34 | 0.090 |
Why?
| | Neuroglia | 1 | 2013 | 176 | 0.090 |
Why?
| | Etoposide | 1 | 2012 | 169 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2012 | 751 | 0.090 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2018 | 929 | 0.090 |
Why?
| | Reactive Oxygen Species | 1 | 2014 | 610 | 0.090 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2017 | 155 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1334 | 0.090 |
Why?
| | Tissue Array Analysis | 1 | 2011 | 49 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2024 | 2018 | 0.080 |
Why?
| | Metabolic Networks and Pathways | 1 | 2012 | 175 | 0.080 |
Why?
| | Repressor Proteins | 1 | 2014 | 428 | 0.080 |
Why?
| | Proteasome Inhibitors | 1 | 2011 | 42 | 0.080 |
Why?
| | Cell Death | 2 | 2021 | 379 | 0.080 |
Why?
| | Antioxidants | 1 | 2014 | 544 | 0.080 |
Why?
| | Lymphatic Metastasis | 1 | 2012 | 335 | 0.080 |
Why?
| | Energy Metabolism | 1 | 2017 | 930 | 0.080 |
Why?
| | Antigens, Differentiation | 1 | 2010 | 75 | 0.080 |
Why?
| | Protein Domains | 2 | 2024 | 314 | 0.080 |
Why?
| | DNA Repair | 2 | 2026 | 254 | 0.080 |
Why?
| | Doxorubicin | 1 | 2012 | 414 | 0.080 |
Why?
| | Metaplasia | 1 | 2009 | 54 | 0.070 |
Why?
| | Smad3 Protein | 1 | 2009 | 41 | 0.070 |
Why?
| | Lymphocytes | 1 | 1991 | 379 | 0.070 |
Why?
| | Salivary Proteins and Peptides | 1 | 2009 | 14 | 0.070 |
Why?
| | Follow-Up Studies | 1 | 2019 | 5397 | 0.070 |
Why?
| | Submandibular Gland | 1 | 2009 | 20 | 0.070 |
Why?
| | Mutant Proteins | 1 | 2009 | 103 | 0.070 |
Why?
| | Lymphoma | 1 | 2011 | 251 | 0.070 |
Why?
| | Glioma | 1 | 2013 | 425 | 0.070 |
Why?
| | Lactation | 1 | 2010 | 193 | 0.070 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 944 | 0.070 |
Why?
| | Protein Structure, Secondary | 1 | 2009 | 357 | 0.070 |
Why?
| | Amino Acid Substitution | 1 | 2009 | 295 | 0.070 |
Why?
| | NIH 3T3 Cells | 1 | 2008 | 146 | 0.070 |
Why?
| | Eye Neoplasms | 1 | 2008 | 31 | 0.070 |
Why?
| | Cell Line | 3 | 2014 | 2809 | 0.070 |
Why?
| | Clinical Trials as Topic | 2 | 2012 | 1062 | 0.070 |
Why?
| | Oxidative Stress | 1 | 2014 | 1367 | 0.070 |
Why?
| | Protein Transport | 1 | 2009 | 439 | 0.060 |
Why?
| | Models, Molecular | 5 | 2019 | 1571 | 0.060 |
Why?
| | Ubiquitin | 1 | 2006 | 84 | 0.060 |
Why?
| | Amino Acid Motifs | 1 | 2006 | 217 | 0.060 |
Why?
| | Myeloid Ecotropic Viral Integration Site 1 Protein | 1 | 2026 | 11 | 0.060 |
Why?
| | DNA | 2 | 2009 | 1418 | 0.060 |
Why?
| | Crystallography, X-Ray | 2 | 2019 | 477 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2012 | 4565 | 0.060 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 2005 | 23 | 0.060 |
Why?
| | Antigens, CD1 | 1 | 2005 | 59 | 0.060 |
Why?
| | Ovary | 1 | 2007 | 235 | 0.050 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2026 | 72 | 0.050 |
Why?
| | Chickens | 1 | 2005 | 169 | 0.050 |
Why?
| | Molecular Structure | 2 | 2024 | 483 | 0.050 |
Why?
| | PAX3 Transcription Factor | 1 | 2024 | 16 | 0.050 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2025 | 120 | 0.050 |
Why?
| | Paired Box Transcription Factors | 1 | 2024 | 42 | 0.050 |
Why?
| | Precipitin Tests | 1 | 2004 | 90 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2025 | 180 | 0.050 |
Why?
| | Mice, Transgenic | 1 | 2009 | 2131 | 0.050 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2024 | 64 | 0.050 |
Why?
| | Phylogeny | 2 | 2005 | 921 | 0.050 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2024 | 194 | 0.050 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2025 | 299 | 0.050 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2003 | 33 | 0.050 |
Why?
| | Dogfish | 1 | 2003 | 4 | 0.050 |
Why?
| | Cyclin D1 | 1 | 2003 | 64 | 0.050 |
Why?
| | Molecular Sequence Data | 5 | 2014 | 2835 | 0.050 |
Why?
| | Dideoxyadenosine | 2 | 2000 | 4 | 0.050 |
Why?
| | Cell Lineage | 1 | 2025 | 375 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2003 | 269 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2025 | 441 | 0.050 |
Why?
| | Cell Division | 1 | 2004 | 735 | 0.050 |
Why?
| | Fibroblasts | 1 | 2008 | 1033 | 0.050 |
Why?
| | Neovascularization, Pathologic | 1 | 2004 | 285 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2010 | 6021 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 366 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2005 | 501 | 0.040 |
Why?
| | Kinetics | 2 | 2012 | 1553 | 0.040 |
Why?
| | Deoxyadenine Nucleotides | 1 | 2000 | 16 | 0.040 |
Why?
| | HIV Reverse Transcriptase | 1 | 2000 | 32 | 0.040 |
Why?
| | Developmental Biology | 1 | 2020 | 24 | 0.040 |
Why?
| | Neural Stem Cells | 1 | 2021 | 167 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 568 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2014 | 382 | 0.040 |
Why?
| | Consensus | 1 | 2020 | 465 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2020 | 253 | 0.030 |
Why?
| | Sp7 Transcription Factor | 1 | 2017 | 7 | 0.030 |
Why?
| | Zygoma | 1 | 2017 | 7 | 0.030 |
Why?
| | Serrate-Jagged Proteins | 1 | 2017 | 27 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.030 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.030 |
Why?
| | Branchial Region | 1 | 2017 | 40 | 0.030 |
Why?
| | Receptor, Endothelin A | 1 | 2017 | 60 | 0.030 |
Why?
| | Male | 6 | 2024 | 73014 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2012 | 11744 | 0.030 |
Why?
| | Pregnancy | 1 | 2010 | 7217 | 0.030 |
Why?
| | Quinaldines | 1 | 1996 | 1 | 0.030 |
Why?
| | Orotic Acid | 1 | 1996 | 3 | 0.030 |
Why?
| | DNA Primers | 3 | 2005 | 487 | 0.030 |
Why?
| | Autophagy-Related Proteins | 1 | 2016 | 46 | 0.030 |
Why?
| | Diphtheria Toxin | 1 | 2016 | 61 | 0.030 |
Why?
| | Craniofacial Abnormalities | 1 | 2017 | 78 | 0.030 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 2 | 2014 | 348 | 0.030 |
Why?
| | Receptors, Notch | 1 | 2017 | 92 | 0.030 |
Why?
| | Ribonucleotides | 1 | 1996 | 26 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2017 | 230 | 0.030 |
Why?
| | Body Patterning | 1 | 2017 | 137 | 0.030 |
Why?
| | Integrases | 1 | 2017 | 117 | 0.030 |
Why?
| | Phosphotyrosine | 1 | 1996 | 38 | 0.030 |
Why?
| | Epidermal Growth Factor | 1 | 2016 | 157 | 0.030 |
Why?
| | Aspartic Acid | 1 | 1996 | 88 | 0.030 |
Why?
| | Sodium Bicarbonate | 1 | 1996 | 48 | 0.030 |
Why?
| | Neural Crest | 1 | 2017 | 130 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 266 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2009 | 423 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2017 | 447 | 0.030 |
Why?
| | Cytidine Triphosphate | 2 | 1993 | 19 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2016 | 407 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 246 | 0.030 |
Why?
| | Adult | 3 | 2015 | 40821 | 0.030 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2014 | 81 | 0.030 |
Why?
| | Carbon-Nitrogen Ligases | 1 | 1993 | 5 | 0.030 |
Why?
| | Leukemia L1210 | 1 | 1993 | 7 | 0.030 |
Why?
| | Calorimetry | 1 | 2014 | 69 | 0.030 |
Why?
| | Colonic Neoplasms | 1 | 1996 | 257 | 0.030 |
Why?
| | Leukemia | 1 | 1996 | 246 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 120 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2016 | 662 | 0.020 |
Why?
| | Zinc Finger E-box-Binding Homeobox 1 | 1 | 2013 | 21 | 0.020 |
Why?
| | Magnesium | 1 | 2014 | 155 | 0.020 |
Why?
| | Amino Acids | 1 | 2017 | 513 | 0.020 |
Why?
| | Phenylhydrazines | 1 | 2012 | 4 | 0.020 |
Why?
| | Miniaturization | 1 | 2012 | 22 | 0.020 |
Why?
| | Protein Phosphatase 2C | 1 | 2012 | 15 | 0.020 |
Why?
| | Fluoresceins | 1 | 2012 | 48 | 0.020 |
Why?
| | Enzyme Assays | 1 | 2012 | 25 | 0.020 |
Why?
| | Time Factors | 2 | 2017 | 7079 | 0.020 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2012 | 67 | 0.020 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 44 | 0.020 |
Why?
| | Spleen | 2 | 2005 | 503 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2012 | 165 | 0.020 |
Why?
| | Kidney Neoplasms | 1 | 1996 | 417 | 0.020 |
Why?
| | Antibody Specificity | 1 | 2012 | 181 | 0.020 |
Why?
| | Sequence Analysis, DNA | 2 | 2005 | 771 | 0.020 |
Why?
| | DNA Fragmentation | 1 | 2011 | 42 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2013 | 331 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 61 | 0.020 |
Why?
| | Software | 1 | 1996 | 673 | 0.020 |
Why?
| | High-Throughput Screening Assays | 1 | 2012 | 179 | 0.020 |
Why?
| | Drug Synergism | 1 | 2011 | 353 | 0.020 |
Why?
| | Melanoma | 1 | 1996 | 764 | 0.020 |
Why?
| | Mitochondria | 1 | 1996 | 996 | 0.020 |
Why?
| | Brain | 1 | 2021 | 2981 | 0.020 |
Why?
| | HIV-1 | 1 | 1995 | 911 | 0.020 |
Why?
| | Azacitidine | 1 | 1990 | 168 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2009 | 334 | 0.020 |
Why?
| | RNA | 2 | 1993 | 925 | 0.020 |
Why?
| | Organ Size | 1 | 2009 | 463 | 0.020 |
Why?
| | Base Sequence | 2 | 2005 | 2119 | 0.020 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 1996 | 1194 | 0.020 |
Why?
| | Bursa of Fabricius | 1 | 2005 | 2 | 0.010 |
Why?
| | Blotting, Southern | 1 | 2005 | 82 | 0.010 |
Why?
| | Sequence Homology | 1 | 2005 | 42 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2005 | 197 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2005 | 242 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2005 | 360 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2005 | 505 | 0.010 |
Why?
| | Databases, Genetic | 1 | 2003 | 239 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2003 | 526 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2009 | 3121 | 0.010 |
Why?
| | Dideoxynucleotides | 1 | 2000 | 17 | 0.010 |
Why?
| | Dinucleoside Phosphates | 1 | 2000 | 32 | 0.010 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2000 | 88 | 0.010 |
Why?
| | HIV Infections | 1 | 1995 | 3210 | 0.010 |
Why?
| | Models, Chemical | 1 | 2000 | 252 | 0.010 |
Why?
| | Biological Evolution | 1 | 2003 | 471 | 0.010 |
Why?
| | Thermodynamics | 1 | 2000 | 418 | 0.010 |
Why?
| | Genetic Variation | 1 | 2003 | 992 | 0.010 |
Why?
| | Protein Conformation | 1 | 2000 | 914 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2005 | 2228 | 0.010 |
Why?
| | Binding Sites | 1 | 2000 | 1306 | 0.010 |
Why?
| | Chemistry, Physical | 1 | 1996 | 36 | 0.010 |
Why?
| | Fluorine | 1 | 1996 | 18 | 0.010 |
Why?
| | Chemical Phenomena | 1 | 1996 | 75 | 0.010 |
Why?
| | src Homology Domains | 1 | 1996 | 34 | 0.010 |
Why?
| | Ions | 1 | 1996 | 66 | 0.010 |
Why?
| | Cricetinae | 1 | 1996 | 295 | 0.010 |
Why?
| | Genes, env | 1 | 1995 | 5 | 0.010 |
Why?
| | Proviruses | 1 | 1995 | 16 | 0.010 |
Why?
| | Lymphocyte Transfusion | 1 | 1995 | 20 | 0.010 |
Why?
| | Lymphocyte Count | 1 | 1995 | 166 | 0.010 |
Why?
| | Viremia | 1 | 1995 | 158 | 0.010 |
Why?
| | Deamination | 1 | 1993 | 6 | 0.010 |
Why?
| | Ligases | 1 | 1993 | 38 | 0.010 |
Why?
| | Middle Aged | 2 | 2013 | 36359 | 0.010 |
Why?
| | DNA, Viral | 1 | 1995 | 352 | 0.010 |
Why?
| | Drug Resistance | 1 | 1993 | 145 | 0.010 |
Why?
| | Anti-HIV Agents | 1 | 2000 | 914 | 0.010 |
Why?
| | Immunotherapy, Adoptive | 1 | 1995 | 356 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1995 | 1223 | 0.000 |
Why?
| | Drug Evaluation | 1 | 1990 | 78 | 0.000 |
Why?
| | Leukopenia | 1 | 1990 | 33 | 0.000 |
Why?
| | Antiviral Agents | 1 | 1995 | 774 | 0.000 |
Why?
| | Neutropenia | 1 | 1990 | 153 | 0.000 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 1995 | 1148 | 0.000 |
Why?
| | Thrombocytopenia | 1 | 1990 | 205 | 0.000 |
Why?
| | Drug Administration Schedule | 1 | 1990 | 782 | 0.000 |
Why?
| | Antibodies, Monoclonal | 1 | 1995 | 1511 | 0.000 |
Why?
| | Aged | 1 | 1990 | 26251 | 0.000 |
Why?
|
|
Ford's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|